VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

iwMyeloma 2015 | Novel immunotherapies for the treatment of multiple myeloma

At the Myeloma 2015 meeting, Prof Paul Richardson (Dana-Farber Cancer Institute, Boston, MA) provides an overview of potential new immune-based approaches for the treatment of multiple myeloma. Studies of antibodies, checkpoint inhibitors and immunomodulatory drugs are currently in evaluation in multiple clinical trials. Combination approaches are receiving interest too.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter